Alpharmaxim full lockup logo

Treatment

Challenges in rare diseases:

Misplaced treatment expectations

Challenges to find the right treatment (if any):

  • Limited number of effective treatments
  • Lack of meaningful, real-world evidence or clear treatment guidelines
  • Treatment may only target symptoms, not cure

95% of rare conditions have no licensed treatment in the UK1

Access

Treatments may be available but not accessible:

  • Reimbursement challenges for treatments that are considered too costly compared with perceived value of treatment
  • Challenging treatment regimens for patients
  • Limited access to treatment centres or specialists

Demonstration of real-life benefits

Reservations around initiating or continuing therapy:

  • Lack of real-world evidence on patient outcomes and improved quality of life
  • Concern for potential therapeutic side effects, leading to lower patient satisfaction compared with no treatment
  • No perceived benefit after treatment commencement
  • Perception of patient being ‘cured’ or no longer needing expensive ongoing treatment

References

 
1. Slade A, Isa F, Kyte D, et al. Patient reported outcome measures in rare diseases: a narrative review. Orphanet J Rare Dis 2018;13(1):61

Talk to us about how we can transform your communications

It's time for behavioural science to take centre stage in health communications

It's time for behavioural science to take centre stage in health communications

It’s time for behavioural science to take centre stage in healthcare communications Dan Parkinson, Principal Copywriter at Alpharmaxim Healthcare Communications In 1977 The Jam sang,…
Why Plain Language Summaries are vital in rare disease communications

Why Plain Language Summaries are vital in rare disease communications

Plain language summaries can translate complex science for different audiences. But what are they, and how do they improve awareness?
What can COVID-19 campaigns tell us about increasing vaccine uptake?

What can COVID-19 campaigns tell us about increasing vaccine uptake?

We examine what lessons we can take from the COVID-19 vaccine campaigns, and how behavioural science insights may help to drive vaccine uptake.